Forecasting drug utilization and expenditure: ten years of experience in Stockholm

National trends in prescription drug expenditures and projections for 2019

(2019) Glen T Schumock et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Eliminated patient fee and changes in dispensing patterns of asthma medication in children—An interrupted time series analysis

(2019) Elin Dahlén et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations

(2018) Irene Eriksson et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden

(2018) P. Frisk et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Price competition in pharmaceuticals – Evidence from 1303 Swedish markets

(2018) David Granlund et al.   JOURNAL OF HEALTH ECONOMICS

Regulation of biosimilar medicines and current perspectives on interchangeability and policy

(2018) J. O’Callaghan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates

(2018) Jaime Espin et al.   Applied Health Economics and Health Policy

Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System

(2018) Irene Eriksson et al.   Applied Health Economics and Health Policy

National Health Expenditure Projections, 2016–25: Price Increases, Aging Push Sector To 20 Percent Of Economy

(2017) Sean P. Keehan et al.   HEALTH AFFAIRS

Payers’ experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia

(2017) Steven G. Morgan et al.   HEALTH POLICY

The Early Awareness and Alert System in Sweden: History and Current Status

(2017) Irene Eriksson et al.   Frontiers in Pharmacology

Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015

(2016) Sabine Vogler et al.   HEALTH POLICY

The High Cost of Prescription Drugs in the United States

(2016) Aaron S. Kesselheim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Biosimilars: How Can Payers Get Long-Term Savings?

(2016) Jorge Mestre-Ferrandiz et al.   PHARMACOECONOMICS

Forecasting Medicaid Expenditures for Antipsychotic Medications

(2015) Eric P. Slade et al.   PSYCHIATRIC SERVICES

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

(2014) Brian Godman et al.   Expert Review of Clinical Pharmacology

Pharmaceutical forecasting: throwing darts?

(2013) Myoung Cha et al.   NATURE REVIEWS DRUG DISCOVERY

Projecting Expenditure on Medicines in the UK NHS

(2013) Phill O’Neill et al.   PHARMACOECONOMICS

Forecasting drug utilization and expenditure in a metropolitan health region

(2012) Björn Wettermark et al.   BMC HEALTH SERVICES RESEARCH

Estimating the budget impact of orphan medicines in Europe: 2010 - 2020

(2011) Carina Schey et al.   Orphanet Journal of Rare Diseases

Recent National and Regional Drug Reforms in Sweden

(2009) Björn Wettermark et al.   PHARMACOECONOMICS

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

(2009) Brian Godman et al.   Expert Review of Pharmacoeconomics & Outcomes Research